Hyperuricemia in non-alcoholic fatty liver disease

Alimentary Pharmacology and Therapeutics

Volumn 34, Issue 8, 2011, Pages 1042-1043

  Dogru, T ^a   Genc, H ^a   Tapan, S ^a   Bagci, S ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; URIC ACID;

DISEASE ASSOCIATION; DISEASE SEVERITY; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; HYPERTENSION; HYPERURICEMIA; LETTER; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL;

FATTY LIVER; FEMALE; HUMANS; HYPERURICEMIA; MALE; URIC ACID;

EID: 80053182628     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04828.x     Document Type: Letter

References (10)

1. Petta S, Cammà C, Cabibi D, Di Marco V, Craxì A,. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2011; 34: 757-66.
2. Yun JW, Cho YK, Park JH, et al. Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease. Liver Int. 2009; 29: 525-29.
3. Hairong Nan, Zengchang Pang, Shaojie Wang, et al. Serum uric acid, plasma glucose and diabetes. Diab Vasc Dis Res 2010; 7: 40-6.
4. Nan H, Dong Y, Gao W, Tuomilehto J, Qiao Q,. Diabetes associated with a low serum uric acid level in a general Chinese population. Diabetes Res Clin Pract 2007; 76: 68-74. (Pubitemid 46240355)
5. Yuan HJ, Yang XG, Shi XY, Tian R, Zhao ZG,. Association of serum uric acid with different levels of glucose. Chin Med J (Engl) 2011; 124: 1443-8.
6. Indulekha K, Anjana RM, Surendar J, Mohan V,. Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians. Clin Biochem 2011; 44: 281-7.
7. Halvorsen B, Heggen E, Ueland T, et al. Treatment with the PPARgamma agonist rosiglitazone downregulates interleukin-1 receptor antagonist in individuals with metabolic syndrome. Eur J Endocrinol 2010; 162: 267-73.
8. Riera-Guardia N, Rothenbacher D,. The effect of thiazolidinediones on adiponectin serum level: a meta-analysis. Diabetes Obes Metab 2008; 10: 367-75. (Pubitemid 351524284)
9. Matafome P, Louro T, Rodrigues L, et al. Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia. Diabetes Metab Res Rev 2011; 27: 54-62.
10. Miyazaki Y, Mahankali A, Wajcberg E, Bajaj M, Mandarino LJ, DeFronzo RA,. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 2004; 89: 4312-9. (Pubitemid 39244431)